| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/16/2008 | EP1091753B1 Antiproliferative and antiviral proteins and peptides |
| 01/16/2008 | EP1085848B1 Inhibitors of transcription factor nf-kappa b |
| 01/16/2008 | EP0938486B1 Substituted pyrrolopyrimidines and processes for their preparation |
| 01/16/2008 | EP0837927B1 Anti-cd80 antibodies |
| 01/16/2008 | CN101107267A Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 01/16/2008 | CN101107261A Imidazopyridine derivative |
| 01/16/2008 | CN101107259A Silicon compounds and their use |
| 01/16/2008 | CN101107253A Mitotic kinesin inhibitors |
| 01/16/2008 | CN101107001A Anticancer drug containing alpha, alpha, alpha-trifluorothymidine and thymidine phosphorylase inhibitor |
| 01/16/2008 | CN101106983A Combinations comprising JAK inhibitors and at least one of Bcr-Abl, Flt-3, FAK or RAF kinase inhibitors |
| 01/16/2008 | CN101106980A Perfluorocarbon liquids as carcinogen |
| 01/16/2008 | CN101104854A Antihuman telomere enzyme reverse transcriptase single-chain antibody |
| 01/16/2008 | CN101104852A Human new gene LOC344967 correlated with nasopharyngeal carcinoma and coding protein product thereof |
| 01/16/2008 | CN101104646A Preparation method for eucheuma gelatinae polysaccharide selenide and application |
| 01/16/2008 | CN101104644A Preparation for polysaccharide selenite and application thereof |
| 01/16/2008 | CN101104643A Polysaccharide sulfate selenide compound and its preparation method and application |
| 01/16/2008 | CN101104630A Wheat bran flavonoid compounds |
| 01/16/2008 | CN101104615A Anticancer cytoskeleton inhibiting and cell elongation inducing compound and synthetic method thereof |
| 01/16/2008 | CN101104611A 3-methoxylflavonoid compound, preparation method and application thereof |
| 01/16/2008 | CN101104610A 4-deoxyisopodophyllotoxin derivatives, preparation and medicinal uses thereof |
| 01/16/2008 | CN101104609A Solanesyl polyamine derivative, preparation and application thereof |
| 01/16/2008 | CN101104608A Solanesol derivative, preparation and application thereof |
| 01/16/2008 | CN101104078A Polypeptide and protein medicine polyethylene coupling compound |
| 01/16/2008 | CN101104077A Recombinant human interleukin-2 and polyethylene coupling compound |
| 01/16/2008 | CN101104031A Internal-applied traditional Chinese medicine composition for treating nasopharyngeal cancer |
| 01/16/2008 | CN101104011A Medicine for curing malignant tumor and its preparation method |
| 01/16/2008 | CN101104008A Preparation of traditional Chinese medicine active component with anti-tumor activity and application thereof |
| 01/16/2008 | CN101104006A Method for preparing Chinese caterpillar fungus extracting concentrated liquid and application thereof |
| 01/16/2008 | CN101104003A Xuezhikang purpose-made monascus anti-cancer new use |
| 01/16/2008 | CN101104000A Polypeptide protein active material in scapharca broughtonii and preparation method and application thereof |
| 01/16/2008 | CN101103988A Application of 23-hydroxylbetulinic acid in preparing medicine for treating and preventing lung cancer |
| 01/16/2008 | CN101103987A Application of 23-hydroxylbetulinic acid in preparing medicine for treating and preventing AIDS |
| 01/16/2008 | CN101103986A Application of 23-hydroxylbetulinic acid in preparing medicine for treating and preventing liver cancer |
| 01/16/2008 | CN101103976A Oral medicinal composition containing anastrozole and preparation technology thereof |
| 01/16/2008 | CN101103973A Anti-tumor medicine |
| 01/16/2008 | CN101103972A Oxaliplatinum liposome glucose preparation and its preparation method and application |
| 01/16/2008 | CN100362018C Recombinant monoclonal antibody against EGFR |
| 01/16/2008 | CN100362010C Mevalonic acid derivative |
| 01/16/2008 | CN100362005C Ruthenium anticancer complexes |
| 01/16/2008 | CN100361985C Paclitaxol predrug of biodegradable polymer and its synthesis method |
| 01/16/2008 | CN100361710C Construction and application of oncolytic adenovirus recombinant of tumor cell specifically expressing immunoregulation factor GM-CSF |
| 01/16/2008 | CN100361657C Fluorouracial nano particle formulation and its preparing method |
| 01/15/2008 | US7319933 Gene transcription assay method |
| 01/15/2008 | US7319148 Comprising reactive hydrazide function used as initial synthons for preparing compounds capable of inducing mutations or capable of inhibiting a DNA polymerase or a kinase |
| 01/15/2008 | US7319145 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 01/15/2008 | US7319139 TAG-72 specific CH2 domain deleted antibodies |
| 01/15/2008 | US7319138 Comprises transcription factor referred to as dragon protein (DRG) for treating and diagnosing nervous system, skin, muscle, bone and eye disorders |
| 01/15/2008 | US7319134 Polypeptide having a modified amino acid sequence of a fragment of nuclear factor-interleukin 6/lymphokine activating protein; activateS various target genes, such as cytokine genes; regulation of gene expression; antiproliferative agents |
| 01/15/2008 | US7319105 Cytotoxic agents |
| 01/15/2008 | US7318928 Molecular vaccine linking intercellular spreading protein to an antigen |
| 01/15/2008 | US7318924 Antibodies against cancer |
| 01/15/2008 | CA2508238C Reovirus for the treatment of neoplasia |
| 01/15/2008 | CA2419934C Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |
| 01/15/2008 | CA2335514C Alkyl ether analogs of chlorins having an n-substituted imide ring |
| 01/15/2008 | CA2319763C Cholenic acid amides and pharmaceutical compositions thereof |
| 01/15/2008 | CA2265666C Cytostatic hydroxamic acid derivatives |
| 01/15/2008 | CA2250880C Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 01/11/2008 | CA2552493A1 Methods for producing interfering rnas |
| 01/10/2008 | WO2008006113A2 Novel belactosin derivatives as therapeutic agents/biological probes and their synthesis |
| 01/10/2008 | WO2008006040A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | WO2008006039A1 Dihydrothieno pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | WO2008006032A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | WO2008006025A1 Dihydrofuro pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | WO2008005956A2 Pyrrolotriazine kinase inhibitors |
| 01/10/2008 | WO2008005954A2 Tryphostin-analogs for the treatment of cell proliferative diseases |
| 01/10/2008 | WO2008005859A2 Dendritic cells generated using gm-csf and interferon alpha and loaded with heat-treated and killed cancer cells |
| 01/10/2008 | WO2008005570A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/10/2008 | WO2008005268A1 Substituted piperidines that increase p53 activity and the uses thereof |
| 01/10/2008 | WO2008005262A1 Substituted bicyclic and tricyclic thrombin receptor antagonists |
| 01/10/2008 | WO2008004978A1 Micelles for drug delivery |
| 01/10/2008 | WO2008004948A1 8-oxoadenine derivatives acting as modulators of tlr7 |
| 01/10/2008 | WO2008004836A1 Triazine derivative compound and composition for treating cancer containing them |
| 01/10/2008 | WO2008004760A1 Antibody specifically binding to dr5 and composition for preventing or treating cancers comprising the same |
| 01/10/2008 | WO2008004653A1 Prophylactic or therapeutic agent for viral disease |
| 01/10/2008 | WO2008004542A1 Method of separating vesicle, process for producing medicinal preparation, and method of evaluation |
| 01/10/2008 | WO2008004341A1 α-SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES |
| 01/10/2008 | WO2008004231A1 Anti-cancer therapy comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent |
| 01/10/2008 | WO2008003857A1 Pyrazolylbenzimidazole derivatives, compositions containing them and use thereof |
| 01/10/2008 | WO2008003855A2 Use of 2-benzoyl-imidazopyridines in therapeutics |
| 01/10/2008 | WO2008003809A1 Antitumour compounds |
| 01/10/2008 | WO2008003770A1 Phenyl substituted heteroaryl-derivatives and use thereof as anti-tumor agents |
| 01/10/2008 | WO2008003511A1 Use of aminothiazole derivative compounds, pharmaceutical compositions thereof, in the treatment of diseases characterized by abnormal repression of gene transcription, particularly huntington's disease |
| 01/10/2008 | WO2008003396A1 Indazole derivatives for treating hsp90-induced diseases |
| 01/10/2008 | WO2008003378A1 Sulfamate benzothiophene derivatives |
| 01/10/2008 | WO2008003185A1 Use of extracts or extractants of the guajacum types, said extracts or extractants bringing about phosphodiesterase-4 inhibition and method for producing the same |
| 01/10/2008 | WO2008003141A1 Therapeutic compounds |
| 01/10/2008 | WO2007135295A3 Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same |
| 01/10/2008 | WO2007128987A3 Therapy targeting cathepsin s |
| 01/10/2008 | WO2007117995A3 Kinase inhibitors |
| 01/10/2008 | WO2007117692A3 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases |
| 01/10/2008 | WO2007070671A3 Therapeutic methods for inhibiting tumor growth with dll4 antagonists |
| 01/10/2008 | WO2007062855A3 Radioimmunoconjugate for human cd66 for the treatment of multiple myeloma |
| 01/10/2008 | WO2007057457A3 Neuroendocrine tumor treatment using mtor inhibitors |
| 01/10/2008 | WO2007044892A3 Upar-binding molecule-drug conjugates and uses thereof |
| 01/10/2008 | WO2007026725A3 Drug, drug gudance system, magnetic detection system, and drug design method |
| 01/10/2008 | WO2006108488A8 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents |
| 01/10/2008 | WO2006090750A8 ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME |
| 01/10/2008 | US20080009631 e.g. 2-[4-[3-[2-(2,4-Dichlorophenyl)-5-isopropyl-4-oxazolyl]propionyl]-2-methylphenoxy]-2-methylpropionic acid; |
| 01/10/2008 | US20080009545 Anticancer agents |
| 01/10/2008 | US20080009527 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |